Sunday, November 15, 2026

Peer-Reviewed Clinical Evidence Platform

The research that matters, without the jargon.

Peer-reviewed breakthroughs in plain English alongside verified outcomes, evidence grades, and clinical study details for everyone from everyday readers to medical students.

ClearMed Editorial Digest500 briefings across 12 specialties121 Phase III & clinical practice

Indexed from PubMed, NEJM, The Lancet, JAMA, Nature MedicineSaved Library

Health Hubs:

Stage: Evidence:

Showing 65 briefings matching “inflammation”

Reset all filters

Filtered Archive

Matching Peer-Reviewed Briefings

Peer-Reviewed Clinical Digests · Verified Scientific Media

NEUROLOGY · CLINICAL PRACTICE

Daily Caffeinated Coffee Intake Linked to Reduced Dementia Risk

Daily consumption of 2-3 cups of caffeinated coffee is strongly associated with a dramatically lower long-term risk of dementia and better cognitive function, independently of genetic predisposition. Dementia currently lacks effective preventative pharmacological interventions, making lifestyle modifications a cornerstone of risk reduction strategies.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 12, 2026

NEUROLOGY · CLINICAL PRACTICE

Clinical Reasoning: A 33-Year-Old Man With Rapidly Progressive Ataxia

Mystery Illness: A Young Man's Fight Against Rapidly Worsening Brain Trouble. Diagnosing brain and nerve problems in patients with weakened immune systems is incredibly complex.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readNeurologyNov 15, 2026

NEUROLOGY · CLINICAL PRACTICE

Pearls & Oy-sters: Anti-GABA A Receptor Encephalitis Presenting as Fulminant Hemicerebellitis in a 5-Year-Old Girl

This case highlights fulminant cerebellitis as a life-threatening presentation of anti-GABA A R encephalitis and underscores the... She later stabilized with radiographic improvement and meaningful neurologic recovery.

2/5 Preclinical

Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readNeurologyNov 15, 2026

IMMUNOLOGY · REAL-WORLD COHORT

A CD4-lineage erythro-myeloid progenitor within the adult bone marrow defines an alternative pathway for macrophage generation

These findings reveal an alternative pathway of adult myelopoiesis that sustains macrophage diversity beyond the classical monocyte lineage. Transcriptomic comparisons position EMPROR cells closest to embryonic erythro-myeloid progenitors, indicating the persistence of an embryonic-like program in adult bone marrow.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readNature ImmunologyNov 15, 2026

NEUROLOGY · CLINICAL PRACTICE

Clinical Reasoning: A 60-Year-Old Woman With Progressive Dysarthric Speech and Gait Instability

Readers will navigate a stepwise clinical reasoning approach to subacute cerebellar ataxia, which illustrates the importance of recognizing systemic red flags and monitoring phenotypic evolution as well as how specialized testing based on positive TBA results can resolve diagnostic dilemmas when commercial assays remain unrevealing. Specialized testing in a neuroimmunology laboratory ultimately revealed the diagnosis.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readNeurologyNov 15, 2026

NEUROLOGY · CLINICAL PRACTICE

Pearls & Oy-sters: Beyond the Bone Marrow-VEXAS Syndrome Presenting as Subacute Encephalomyelitis

Follow-up MRI performed 1 month after presentation showed resolution of contrast enhancement and partial disappearance of spinal T2 hyperintense lesions. Negative infectious PCR testing and the absence of aquaporin 4 and myelin oligodendrocyte glycoprotein antibodies argued against infection or other inflammatory demyelinating condition.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readNeurologyNov 15, 2026

NEUROLOGY · CLINICAL PRACTICE

Establishing Potosi Virus as a Human Pathogen: Fatal Neuroinvasive Disease in a B-Cell-Depleted Patient

Potosi virus can cause fatal neuroinvasive disease in humans, as evidenced by convergent postmortem neuropathologic, molecular, and ultrastructural evidence. Chronic B-cell depletion may increase susceptibility to severe disease with arboviral infections, which may present without conventional CNS inflammatory markers.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readNeurologyNov 15, 2026

IMMUNOLOGY · PRECLINICAL

Evidence for maternal autoantibodies in the pathogenesis of preterm birth

These findings identify a term pregnancy humoral immune program and shared changes preceding preterm delivery, including anti-IL1RA, which may have direct pathogenic consequences. IL1RA localizes to placental endothelial (blood-vessel lining) adherens junctions, suggesting a role in vascular integrity.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readNature ImmunologyNov 14, 2026

PHARMACOLOGY · CLINICAL PRACTICE

Diet, Exercise, Drugs, Not Supplements, Slow Biological Aging

To truly slow your biological clock, prioritize healthy living and evidence-based medicine over unproven anti-aging supplements. This comprehensive review challenges a common belief that expensive, often unproven supplements are the key to unlocking longevity.

4/5 Strong Trial

Evidence Meter · 4/5

Strong Clinical Evidence

Tested directly in patients through a prospective clinical trial or large multicenter human cohort.

1 min readScienceDailyNov 14, 2026

ONCOLOGY · CLINICAL PRACTICE

Decades-Old Mystery Solved: New Anti-Inflammatory Defense Found

A newly identified immune defense mechanism protects healthy cells from inflammation, opening new avenues for treating inflammatory diseases and cancer. This breakthrough offers a novel target for therapeutic interventions in a range of inflammatory conditions.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 12, 2026

NEUROLOGY · PRECLINICAL

Placental Clues to Autism's Sex Bias

Placental health and inflammation during pregnancy may play a critical, sex-specific role in autism development. This finding offers a potential explanation for the higher prevalence of autism spectrum disorder diagnoses in boys compared to girls.

2/5 Preclinical

Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readScienceDailyNov 12, 2026

NEUROLOGY · REAL-WORLD COHORT

Dual-Action Drug Shows Promise Against Alzheimer's DNA Damage and Inflammation

An existing experimental drug shows potential in Alzheimer's by repairing DNA damage and reducing brain inflammation, possibly accelerating new treatment development. The drug's prior successful human safety testing for spinal cord injuries is a significant advantage, potentially expediting its clinical development.

3/5 Observational

Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDailyNov 12, 2026

Showing 12 of 65 medical briefings

Interactive Fact Check